Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Antonicelli

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
European Annals of Allergy and Clinical Immunology|August 27, 2004
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patientsG Senna, M B Bilò, L Antonicelli, et al.
European Annals of Allergy and Clinical Immunology|November 6, 2019
Anaphylaxis to baobab fruit: the paradox of "natural healthy food"M Martini, G Mistrello, S Amato, et al.
Allergy|April 9, 2008
Improving latex-allergy diagnosis: the clinical role of Hev b8-specific IgEL Antonicelli, C Micucci, G Mistrello, et al.
Respiratory Medicine|December 13, 2005
Asthma-related resource use and cost by GINA classification of severity in three European countriesE Van Ganse, L Antonicelli, Q Zhang, et al.
Journal of Investigational Allergology & Clinical Immunology|February 1, 1991
Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria)F Bonifazi, L Antonicelli, M B Bilò, et al.
Respiratory Medicine|June 2, 2011
Congruence between international guidelines and mite specific immunotherapy prescribing practicesL Antonicelli, M C Braschi, M B Bilò, et al.
Allergy|August 10, 2007
Relationship between ARIA classification and drug treatment in allergic rhinitis and asthmaL Antonicelli, C Micucci, S Voltolini, et al.
European Annals of Allergy and Clinical Immunology|October 10, 2025
Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registryF Menzella, M Martini, M B Bilò, et al.
European Annals of Allergy and Clinical Immunology|March 17, 2021
Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA)M B Bilò, L Antonicelli, M Carone, et al.
Journal of Investigational Allergology & Clinical Immunology|January 1, 1995
Comparative study of terfenadine and cetirizine in hay fever: assessment of efficacy and central nervous system effectsF Bonifazi, L Provinciali, L Antonicelli, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
European Annals of Allergy and Clinical Immunology|August 27, 2004
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patientsG Senna, M B Bilò, L Antonicelli, et al.
European Annals of Allergy and Clinical Immunology|November 6, 2019
Anaphylaxis to baobab fruit: the paradox of "natural healthy food"M Martini, G Mistrello, S Amato, et al.
Allergy|April 9, 2008
Improving latex-allergy diagnosis: the clinical role of Hev b8-specific IgEL Antonicelli, C Micucci, G Mistrello, et al.
Respiratory Medicine|December 13, 2005
Asthma-related resource use and cost by GINA classification of severity in three European countriesE Van Ganse, L Antonicelli, Q Zhang, et al.
Journal of Investigational Allergology & Clinical Immunology|February 1, 1991
Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria)F Bonifazi, L Antonicelli, M B Bilò, et al.
Respiratory Medicine|June 2, 2011
Congruence between international guidelines and mite specific immunotherapy prescribing practicesL Antonicelli, M C Braschi, M B Bilò, et al.
Allergy|August 10, 2007
Relationship between ARIA classification and drug treatment in allergic rhinitis and asthmaL Antonicelli, C Micucci, S Voltolini, et al.
European Annals of Allergy and Clinical Immunology|October 10, 2025
Analysis of trends in single inhaler triple therapy (SITT) use and clinical characteristics of patients with severe asthma: data from the IRSA registryF Menzella, M Martini, M B Bilò, et al.
European Annals of Allergy and Clinical Immunology|March 17, 2021
Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA)M B Bilò, L Antonicelli, M Carone, et al.
Journal of Investigational Allergology & Clinical Immunology|January 1, 1995
Comparative study of terfenadine and cetirizine in hay fever: assessment of efficacy and central nervous system effectsF Bonifazi, L Provinciali, L Antonicelli, et al.
Pageof 6